Ausgabe 9/2023
Inhalt (37 Artikel)
Dylan V. Miller and Monica P. Revelo. Diagnostic Pathology: Cardiovascular, 3rd Edition
Luigi Mansi
European guidelines update on PSMA PET/CT for prostate cancer staging—snap back to reality
Fabrizia Gelardi, Alberto Briganti, Cristiano Pini, Gaia Ninatti, Giorgio Gandaglia, Francesco Montorsi, Arturo Chiti
The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe—the nuclear medicine perspective
Roberto C. Delgado Bolton, Francesco Giammarile, David C. Howlett, Nuria Jornet, Adrian P. Brady, Mary Coffey, Monika Hierath, Jonathan Clark, Wolfgang Wadsak
Superfluous, controversial and luxury issues in nuclear medicine
Ozgul Ekmekcioglu, Samantha Y A Terry, Silvia Morbelli, Juliano J. Cerci, Helle D Zacho, Steffie Peters, Xavier Boulvard Chollet, Fred Verzijlbergen
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer
Roberto C. Delgado Bolton, Adriana K. Calapaquí Terán, José Javier Gómez Román, Giorgio Treglia, Francesco Giammarile
Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models
Wenyu Song, Weijun Wei, Xiaoli Lan, Weibo Cai
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
Pablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, Caroline Stokke, Glenn Flux, Francesco Cicone, Mark Konijnenberg, Matt Aldridge, Mattias Sandstrom, Carlo Chiesa, Maria Paphiti, Eero Hippeläinen, Carlos Uribe, Pavel Solny, Silvano Gnesin, Peter Bernhardt, Nicolas Chouin, Pedro Fragoso Costa, Gerhard Glatting, Frederik Verburg, Jonathan Gear
Present and future of target therapies and theranostics: Refining traditions and exploring new frontiers
Barbara Hertz, Bennett S. Greenspan
PET imaging of PARP expression using 68Ga-labelled inhibitors
Xiangwei Wang, Wei Liu, Ke Li, Kaiwen Chen, Simin He, Jianping Zhang, Bingxin Gu, Xiaoping Xu, Shaoli Song
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
Dirk Zboralski, Frank Osterkamp, Esben Christensen, Anne Bredenbeck, Anne Schumann, Aileen Hoehne, Eberhard Schneider, Matthias Paschke, Jan Ungewiss, Christian Haase, Liliane Robillard, Andrew D. Simmons, Thomas C. Harding, Minh Nguyen
Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy
Yu Liu, Haocheng Tang, Tianchi Song, Mengxin Xu, Junyi Chen, Xi-Yang Cui, Yuxiang Han, Zhu Li, Zhibo Liu
Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis
Y. A. A. Bacour, M. P. van Kanten, F. Smit, E. F. I. Comans, M. Akarriou, H. C. W. de Vet, A. E. Voskuyl, C. J. van der Laken, Y. M. Smulders
Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging
Michelle C. Williams, Bryan P. Bednarski, Konrad Pieszko, Robert J. H. Miller, Jacek Kwiecinski, Aakash Shanbhag, Joanna X. Liang, Cathleen Huang, Tali Sharir, Sharmila Dorbala, Marcelo F. Di Carli, Andrew J. Einstein, Albert J. Sinusas, Edward J. Miller, Timothy M. Bateman, Mathews B. Fish, Terrence D. Ruddy, Wanda Acampa, M. Timothy Hauser, Philipp A. Kaufmann, Damini Dey, Daniel S. Berman, Piotr J. Slomka
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
Charles D. Chen, Austin McCullough, Brian Gordon, Nelly Joseph-Mathurin, Shaney Flores, Nicole S. McKay, Diana A. Hobbs, Russ Hornbeck, Anne M. Fagan, Carlos Cruchaga, Alison M. Goate, Richard J. Perrin, Guoqiao Wang, Yan Li, Xinyu Shi, Chengjie Xiong, Michael J. Pontecorvo, Gregory Klein, Yi Su, William E. Klunk, Clifford Jack, Robert Koeppe, B. Joy Snider, Sarah B. Berman, Erik D. Roberson, Jared Brosch, Ghulam Surti, Ivonne Z. Jiménez-Velázquez, Douglas Galasko, Lawrence S. Honig, William S. Brooks, Roger Clarnette, David Wallon, Bruno Dubois, Jérémie Pariente, Florence Pasquier, Raquel Sanchez-Valle, Sergey Shcherbinin, Ixavier Higgins, Ilke Tunali, Colin L. Masters, Christopher H. van Dyck, Mario Masellis, Robin Hsiung, Serge Gauthier, Steve Salloway, David B. Clifford, Susan Mills, Charlene Supnet-Bell, Eric McDade, Randall J. Bateman, Tammie L. S. Benzinger
Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma
Jiajin Li, Beiwen Ni, Xiaofeng Yu, Cheng Wang, Lianghua Li, Yun Zhou, Yue Gu, Gang Huang, Jian Hou, Jianjun Liu, Yumei Chen
Radioligand therapies in cancer: mapping the educational landscape in Europe
Valentina Bugani, Luca Battistelli, Maddalena Sansovini, Manuela Monti, Giovanni Paganelli, Ignasi Gich, Albert Flotats, Paola Anna Erba, Jean-Yves Blay, Christian la Fougère, Hendrik Van Poppel, Andreas Charalambous, Ken Herrmann, Alessandro Giordano, Tamás Györke, Christophe Deroose, Federica Matteucci, Ignasi Carrió
The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
Christos Sachpekidis, Vivienn Weru, Annette Kopp-Schneider, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss
Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
Narjess Ayati, Zahra Jamshidi-Araghi, Magdalena Hoellwerth, Gregor Schweighofer-Zwink, Wolfgang Hitzl, Peter Koelblinger, Christian Pirich, Mohsen Beheshti
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
Jacques Darcourt, David Chardin, Véronique Bourg, Jocelyn Gal, Renaud Schiappa, Marie Blonski, Pierre-Malick Koulibaly, Fabien Almairac, Lydiane Mondot, Florence Le Jeune, Laurent Collombier, Aurélie Kas, Luc Taillandier, Antoine Verger
Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography
Milou E. Noltes, Maximilian Bader, Madelon J. H. Metman, Jasper Vonk, Pieter J. Steinkamp, Jan Kukačka, Henriette E. Westerlaan, Rudi A. J. O. Dierckx, Bettien M. van Hemel, Adrienne H. Brouwers, Gooitzen M. van Dam, Dominik Jüstel, Vasilis Ntziachristos, Schelto Kruijff
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in F]FDG PET/CT
Pavel Nikulin, Sebastian Zschaeck, Jens Maus, Paulina Cegla, Elia Lombardo, Christian Furth, Joanna Kaźmierska, Julian M. M. Rogasch, Adrien Holzgreve, Nathalie L. Albert, Konstantinos Ferentinos, Iosif Strouthos, Marina Hajiyianni, Sebastian N. Marschner, Claus Belka, Guillaume Landry, Witold Cholewinski, Jörg Kotzerke, Frank Hofheinz, Jörg van den Hoff
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
Luca Giovanella, Lisa Milan, Wolfgang Roll, Manuel Weber, Simone Schenke, Michael Kreissl, Alexis Vrachimis, Kim Pabst, Tuncel Murat, Petra Petranovic Ovcaricek, Burkhard Riemann, Luca Ceriani, Alfredo Campenni, Rainer Görges
Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients
Jiayue Liu, Xiaoyi Guo, Li Wen, Lixin Wang, Futao Liu, Guohong Song, Hua Zhu, Nina Zhou, Zhi Yang
Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes
Mingzhu Liang, Lizhu Wang, Yitai Xiao, Meilin Yang, Chaoming Mei, Yaqin Zhang, Hong Shan, Dan Li
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection
Shujing Wang, Changsong Qi, Jin Ding, Dan Li, Miao Zhang, Congcong Ji, Fangli Jiang, Fei Teng, Jie Yu, Xueming Qian, Feng Wang, Lin Shen, Jing Gao, Zhi Yang, Cheng Zhang, Hua Zhu
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors
Paola Mapelli, Carolina Bezzi, Francesca Muffatti, Samuele Ghezzo, Francesco Baldassi, Marco Schiavo Lena, Valentina Andreasi, Carla Canevari, Patrizia Magnani, Francesco De Cobelli, Luigi Gianolli, Stefano Partelli, Massimo Falconi, Maria Picchio
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, Michael S. Hofman, Louise Emmett, Jeremie Calais, Joseph R. Osborne, Amir Iravani, Phillip Koo, Liza Lindenberg, Richard P. Baum, Murat Fani Bozkurt, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levent Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Lassmann, Felix M. Mottaghy, Wim J. G. Oyen, Kambiz Rahbar, Heiko Schoder, Irene Virgolini, Lisa Bodei, Stefano Fanti, Uwe Haberkorn, Ken Hermann
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
Xuejun Wen, Pengfei Xu, Xinying Zeng, Jia Liu, Chao Du, Xueyuan Zeng, Xingxing Cheng, Xueqi Wang, Yuanyuan Liang, Tianzhi Zhao, Hongzhang Yang, Huifeng Li, Lingxin Meng, Jianyang Fang, Hongwu Liu, Zijian Zhou, Jingjing Zhang, Xianzhong Zhang, Zhide Guo, Xiaoyuan Chen
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients
Esther M. K. Wit, Gijs H. KleinJan, Anne-Claire Berrens, Roos van Vliet, Pim J. van Leeuwen, Tessa Buckle, Maarten L. Donswijk, Elise M. Bekers, Fijs W. B. van Leeuwen, Henk G. van der Poel
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Yvonne H. W. Derks, Melline G. M. Schilham, Mark Rijpkema, Esther M. M. Smeets, Helene I. V. Amatdjais-Groenen, Annemarie Kip, Sanne A. M. van Lith, Jill van de Kamp, J. P. Michiel Sedelaar, Diederik M. Somford, Michiel Simons, Peter Laverman, Martin Gotthardt, Dennis W. P. M. Löwik, Sandra Heskamp, Susanne Lütje
A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer
Yun Xi, Lili Sun, Xiaoxia Che, Xinyun Huang, Hua Liu, Qun Wang, Hongping Meng, Yuxin Miao, Qian Qu, Wangxi Hai, Biao Li, Weiwei Feng
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
Florian Rosar, Fadi Khreish, Robert J. Marlowe, Andrea Schaefer-Schuler, Caroline Burgard, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin
[68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma
Wei Guo, Yuhang Chen, Xiaojiang He, Hao Fu, Jingxiong Huang, Haojun Chen
PET/CT scan without sedation: how to use total-body PET/CT to salvage child’s involuntary movement?
Yongjiang Li, Juan Wang, Junfeng Hu, Jin Jia, Hongyan Sun, Yumo Zhao, Yingying Hu
[68 Ga]Ga-DOTA-FAPI-04: Focus the lesion in [18F]F-FDG hidden by metformin
Qixin Wang, Yan Zhu, Yue Chen
[18F]-FDG PET/CT is useful for early detection of Stewart-Treves syndrome, in patients with chronic lymphedema
Ryota Ichikawa, Kota Yokoyama, Junichi Tsuchiya, Takeshi Namiki, Ukihide Tateishi
Identification of isolated hepatic sarcoidosis with [18F]FDG and [68 Ga]Ga-FAPI PET/CT
Yizhen Pang, Peipei Wang, Weizhi Xu, Liang Zhao, Haojun Chen